163 related articles for article (PubMed ID: 21512508)
1. Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer model.
Tabata K; Kurosaka S; Watanabe M; Edamura K; Satoh T; Yang G; Abdelfattah E; Wang J; Goltsov A; Floryk D; Thompson TC
Gene Ther; 2011 Oct; 18(10):969-78. PubMed ID: 21512508
[TBL] [Abstract][Full Text] [Related]
2. Macrophages transduced with an adenoviral vector expressing interleukin 12 suppress tumor growth and metastasis in a preclinical metastatic prostate cancer model.
Satoh T; Saika T; Ebara S; Kusaka N; Timme TL; Yang G; Wang J; Mouraviev V; Cao G; Fattah el MA; Thompson TC
Cancer Res; 2003 Nov; 63(22):7853-60. PubMed ID: 14633713
[TBL] [Abstract][Full Text] [Related]
3. Glioma pathogenesis-related protein 1: tumor-suppressor activities and therapeutic potential.
Thompson TC
Yonsei Med J; 2010 Jul; 51(4):479-83. PubMed ID: 20499410
[TBL] [Abstract][Full Text] [Related]
4. Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model.
Saika T; Satoh T; Kusaka N; Ebara S; Mouraviev VB; Timme TL; Thompson TC
Cancer Gene Ther; 2004 May; 11(5):317-24. PubMed ID: 15044961
[TBL] [Abstract][Full Text] [Related]
5. Combined therapeutic effects of adenoviral vector-mediated GLIPR1 gene therapy and radiotherapy in prostate and bladder cancer models.
Fujita T; Satoh T; Timme TL; Hirayama T; Zhu JX; Kusaka N; Naruishi K; Yang G; Goltsov A; Wang J; Vlachaki MT; Teh BS; Brian Butler E; Thompson TC
Urol Oncol; 2014 Feb; 32(2):92-100. PubMed ID: 23433894
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancer.
Satoh T; Timme TL; Saika T; Ebara S; Yang G; Wang J; Ren C; Kusaka N; Mouraviev V; Thompson TC
Hum Gene Ther; 2003 Jan; 14(2):91-101. PubMed ID: 12614561
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancer.
Tabata K; Watanabe M; Naruishi K; Edamura K; Satoh T; Yang G; Abdel Fattah E; Wang J; Goltsov A; Floryk D; Soni SD; Kadmon D; Thompson TC
Prostate Cancer Prostatic Dis; 2009; 12(3):301-9. PubMed ID: 19104507
[TBL] [Abstract][Full Text] [Related]
8. GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy.
Sonpavde G; Thompson TC; Jain RK; Ayala GE; Kurosaka S; Edamura K; Tabata K; Ren C; Goltsov AA; Mims MP; Hayes TG; Ittmann MM; Wheeler TM; Gee A; Miles BJ; Kadmon D
Clin Cancer Res; 2011 Nov; 17(22):7174-82. PubMed ID: 21933889
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of oncolytic adenovirus expressing suicide genes and interleukin-12 in preclinical model of prostate cancer.
Freytag SO; Barton KN; Zhang Y
Gene Ther; 2013 Dec; 20(12):1131-9. PubMed ID: 23842593
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model.
Nasu Y; Bangma CH; Hull GW; Lee HM; Hu J; Wang J; McCurdy MA; Shimura S; Yang G; Timme TL; Thompson TC
Gene Ther; 1999 Mar; 6(3):338-49. PubMed ID: 10435084
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell based PSMA immunotherapy for prostate cancer using a CD40-targeted adenovirus vector.
Williams BJ; Bhatia S; Adams LK; Boling S; Carroll JL; Li XL; Rogers DL; Korokhov N; Kovesdi I; Pereboev AV; Curiel DT; Mathis JM
PLoS One; 2012; 7(10):e46981. PubMed ID: 23056548
[TBL] [Abstract][Full Text] [Related]
12. Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer.
Eastham JA; Grafton W; Martin CM; Williams BJ
J Urol; 2000 Sep; 164(3 Pt 1):814-9. PubMed ID: 10953161
[TBL] [Abstract][Full Text] [Related]
13. Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer.
Fujita T; Timme TL; Tabata K; Naruishi K; Kusaka N; Watanabe M; Abdelfattah E; Zhu JX; Ren C; Ren C; Yang G; Goltsov A; Wang H; Vlachaki MT; Teh BS; Butler EB; Thompson TC
Gene Ther; 2007 Feb; 14(3):227-36. PubMed ID: 17024109
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of adoptive splenocyte transfer following in situ AdIL-12 gene therapy in a mouse prostate cancer model.
Saika T; Kusaka N; Mouraviev V; Satoh T; Kumon H; Timme TL; Thompson TC
Cancer Gene Ther; 2006 Jan; 13(1):91-8. PubMed ID: 16052232
[TBL] [Abstract][Full Text] [Related]
15. Independent contributions of GR-1+ leukocytes and Fas/FasL interactions to induce apoptosis following interleukin-12 gene therapy in a metastatic model of prostate cancer.
Sanford MA; Yan Y; Canfield SE; Hassan W; Selleck WA; Atkinson G; Chen SH; Hall SJ
Hum Gene Ther; 2001 Aug; 12(12):1485-98. PubMed ID: 11506692
[TBL] [Abstract][Full Text] [Related]
16. Radiation improves intratumoral gene therapy for induction of cancer vaccine in murine prostate carcinoma.
Hillman GG; Xu M; Wang Y; Wright JL; Lu X; Kallinteris NL; Tekyi-Mensah S; Thompson TC; Mitchell MS; Forman JD
Hum Gene Ther; 2003 May; 14(8):763-75. PubMed ID: 12804139
[TBL] [Abstract][Full Text] [Related]
17. Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancer.
Naruishi K; Timme TL; Kusaka N; Fujita T; Yang G; Goltsov A; Satoh T; Ji X; Tian W; Abdelfattah E; Men T; Watanabe M; Tabata K; Thompson TC
Cancer Gene Ther; 2006 Jul; 13(7):658-63. PubMed ID: 16485011
[TBL] [Abstract][Full Text] [Related]
18. Tumor-infiltrating macrophages are involved in suppressing growth and metastasis of human prostate cancer cells by INF-beta gene therapy in nude mice.
Zhang F; Lu W; Dong Z
Clin Cancer Res; 2002 Sep; 8(9):2942-51. PubMed ID: 12231540
[TBL] [Abstract][Full Text] [Related]
19. Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer.
Hall SJ; Sanford MA; Atkinson G; Chen SH
Cancer Res; 1998 Aug; 58(15):3221-5. PubMed ID: 9699645
[TBL] [Abstract][Full Text] [Related]
20. Glioma pathogenesis-related protein 1 exerts tumor suppressor activities through proapoptotic reactive oxygen species-c-Jun-NH2 kinase signaling.
Li L; Abdel Fattah E; Cao G; Ren C; Yang G; Goltsov AA; Chinault AC; Cai WW; Timme TL; Thompson TC
Cancer Res; 2008 Jan; 68(2):434-43. PubMed ID: 18199537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
